| Abstract |
Objective To investigate the efficacy of fiberoptic bronchoscopy in the treatment of severe ventilator-associated pneumonia. Methods: Retrospectively selected 60 patients with severe ventilator-associated pneumonia in our hospital from February 2020 to February 2021, and divided them into two groups according to the treatment methods: fiberoptic bronchoscopy adjuvant therapy group (adjuvant therapy group) and conventional therapy group. 30 cases, the clinical efficacy, efficacy indicators and respiratory mechanics indicators of the two groups were statistically analyzed. Results: Compared with 73.33% (22/30) in the conventional treatment group, the total effective rate in the adjuvant treatment group was 93.33% (28/30) higher (χ2=4.320, P<0.05). Compared with the conventional treatment group, the adjuvant treatment group had shorter mechanical ventilation time (P<0.05), shorter pulmonary infection control time (P<0.05), shorter RICU stay time (P<0.05), and shorter recovery time (P<0.05). Before treatment, compared with the conventional treatment group, the patients in the adjuvant treatment group had similar Raw (P>0.05), PIP (P>0.05), WOB (P>0.05), and Cdyn (P>0.05), and after treatment, were similar to Compared with the conventional treatment group, the patients in the adjuvant treatment group had lower Raw (P<0.05), lower PIP (P<0.05), lower WOB (P<0.05), and higher Cdyn (P<0.05); compared with those before treatment , the two groups of patients after treatment had lower Raw (P<0.05), lower PIP (P<0.05), lower WOB (P<0.05), and higher Cdyn (P<0.05). Conclusion: In the treatment of severe ventilator-associated pneumonia, compared with conventional treatment, fiberoptic bronchoscopy adjuvant therapy has a more significant effect.
|